Collegeville, PA, United States of America

Jonathan Steinfeld

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Glaxosmithkline Intellectual Property (No.2) Limited, Glaxosmithkline LLC. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Steinfeld. Retrieved from https://idiyas.com/inventor/jonathan-steinfeld

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Steinfeld

Introduction

Jonathan Steinfeld is an accomplished inventor based in Collegeville, PA, with a focus on biopharmaceutical innovations. He holds two patents that contribute significantly to the field of pediatric medicine. His work primarily addresses the treatment of interleukin 5 (IL-5) mediated diseases in children.

Latest Patents

Steinfeld's latest patents include biopharmaceutical compositions and methods specifically designed for pediatric patients. These compositions aim to treat diseases mediated by interleukin 5 (IL-5) in pediatric subjects, showcasing his commitment to improving healthcare for younger populations.

Career Highlights

Throughout his career, Jonathan has worked with notable companies, including GlaxoSmithKline Intellectual Property Limited and GlaxoSmithKline LLC. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Some of his coworkers include Jahanara Azmi, who has collaborated with him on various projects. Their joint efforts have contributed to advancements in the field of biopharmaceuticals.

Conclusion

Jonathan Steinfeld's contributions to pediatric medicine through his patents and collaborations highlight his dedication to innovation in healthcare. His work continues to pave the way for new treatments that can significantly impact the lives of children suffering from IL-5 mediated diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…